Crinetics Pharmaceuticals Inc (CRNX)

Finanzdaten der Crinetics Pharmaceuticals Inc-Aktie (CRNX)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	0.64	-	0.346	0.988	2.679
Operating Expenses	18.37% 74.17	62.66	59.32	53.98	50.66
Benefits Costs and Expenses	100.00% -	218.54	-	-	-
Costs And Expenses	35.89% 74.17	54.58	59.32	53.98	50.66
Depreciation and Amortization	80.92% 0.474	0.262	0.273	0.28	0.283
Operating Income/Loss	17.35% -73.53	-62.66	-58.98	-52.99	-47.98
Nonoperating Income/Loss	4.54% 7.069	6.762	2.516	2.016	1.983
Income/Loss From Continuing Operations Before Tax	100.29% 0.64	-218.54	0.346	0.988	2.679
Income/Loss From Continuing Operations After Tax	11.37% -66.93	-60.10	-57.46	-50.98	-45.99
Net Income/Loss	11.37% -66.93	-60.10	-57.46	-50.98	-45.99
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	2,256% 72.29	3.068	56.81	54.27	53.91
Diluted Average Shares	2,256% 72.29	3.068	56.81	54.27	53.91
Basic Earnings Per Share	5.68% -0.93	-0.88	-1.01	-0.94	-0.85
Diluted Earnings Per Share	5.68% -0.93	-0.88	-1.01	-0.94	-0.85
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-